Clinical Biochemistry - Endocrine Investigations
Pituitary
Adrenal
Thyroid & Parathyroid
Pancreas
Gonadal
Neuroendocrine
Pituitary
Adrenal
Thyroid & Parathyroid
Pancreas
Gonadal
Neuroendocrine
As part of the changes to the Clinical Biochemistry testing platform and reference ranges, we have taken the opportunity to align further with the Royal College of Pathologists - The communication of critical and unexpected pathology results, which will be replacing our previous Out of Hours protocol.
The Young People’s Diabetes Group at Southmead Hospital offers a great opportunity for young individuals who attend the young person’s diabetes clinic to learn more about managing diabetes and, to connect with others who share similar experiences.
The six-sessions are 90 minutes each and are led by a clinical psychologist where participants can gain valuable support in a safe and understanding environment. Plus, the convenience of joining via computer or mobile phone makes it accessible to everyone.
To join, speak to your diabetes nurse or consultant, or email the psychology team with your name and hospital number at psychologymedicine@nbt.nhs.uk.
Information for patients referred to Clinical Neuropsychology at North Bristol NHS Trust.
You might be referred to see a neuropsychologist for a number of reasons including:
You have been sent this appointment for an assessment:
The primary purpose of your assessment will be explained to you at your appointment.
Neuropsychologists are psychologists who specialise in understanding the link between the brain and behaviour.
Neuropsychological assessments are a way of describing and measuring the effects that changes in the brain can have on thinking skills, behaviour, and emotion.
Changes in thinking skills and behaviour may be caused by aging, brain damage or disease, and sometimes by stress or low mood.
Neuropsychologists also commonly provide rehabilitation and treatment to help people manage and work around any difficulties they might have.
Your appointment will be with one or more members of the neuropsychology team. Usually, you will discuss your difficulties with the neuropsychologist, who will take notes of what you say. These notes will become part of your healthcare record. You will be able to ask questions.
You can have someone with you, such as a friend or family member, if that is helpful, for example for support or because they can offer helpful information about your difficulties. This discussion will happen either over the phone, video-call, or face to face.
If appropriate, you will have an assessment of your thinking skills, such as your memory ability, and of how you are feeling emotionally. This will be done either face to face or by video-call, through questionnaires and cognitive tests. The assessment requires concentration and effort and some people may feel tired afterwards.
Details of your appointment will be in your letter.
Once you have completed the assessment the neuropsychologist will write a report of the findings and may contact you to discuss the results and possible ways forward. The report will be shared with your referring doctor and other members of your healthcare team as appropriate.
A copy may be sent to you routinely, or if not, is available upon request.
A neuropsychology report typically includes an explanation of the tasks given and the scores that were achieved. It may include an opinion about the likely cause of any difficulties observed as well as some recommendations for how to help with any problems identified.
Sometimes the report might be difficult to understand or you might have further questions, in which case you should contact us so that we can assist you.
Depending on the service pathway, and what was agreed with the neuropsychologist, you may have further appointments with members of the neuropsychology team to help you with your cognitive and/or emotional difficulties.
You will be asked by the neuropsychologist if you agree (consent) to the assessment and, if appropriate, any relevant treatment. The neuropsychologist will explain the assessment and/or treatment to you and you can ask any questions that you may have.
You are free to decide whether or not you want to have the assessment or treatment offered.
By consenting you agree that:
We will process personal data to enable us to provide neuropsychological services to you. This information may include personal details, family details, lifestyle and social circumstances, employment and education details, and physical and mental health details.
In order to carry out our work we need to process personal information about our patients, their relatives/guardians and sometimes other professionals.
We sometimes need to share the personal information we process with the individual, and also with other organisations. Where this is necessary we are required to comply with all aspects of relevant law.
Information discussed and shared with the neuropsychologist or staff under their supervision, along with the results of any assessment or treatment undertaken and reports or letters written, will remain confidential within your healthcare record.
We will share this information with members of your healthcare team as part of your care. We will not share this information with people outside of your healthcare team without your permission.
There are, however, circumstances in which we are legally required to breach confidentiality. Under these circumstances we will make all reasonable efforts to inform you of the need to share information. We will breach confidentiality if we believe failure to do so will result in harm to you or others. Specifically, we will breach confidentiality if we believe a child is at serious risk of harm, we believe there is serious risk of harm to you or someone else, or if we believe you have not disclosed relevant information that you are required by law to disclose, such as a condition that will likely affect your ability to safely work or drive.
Staff within the Department of Neuropsychology receive supervision of their work from a senior clinician to maintain and improve their skills. Within this they may discuss details of their treatment with you. The supervisor is bound by the same rules of confidentiality as outlined above.
North Bristol NHS Trust is a teaching trust and we often have students and trainees working within the Department of Neuropsychology. If you do not wish for them to be present during your assessment or treatment please let us know. Your decision will not affect the treatment you receive.
You may not wish to raise a complaint, but would like us to be aware of an issue and try and make it right. If you need advice or have a concern at North Bristol NHS Trust the Patient Advice and Liaison Service (PALS) can be contacted at:
Email: pals@nbt.nhs.uk
Phone: 0117 414 4569
If you wish to make a formal complaint you can:
Complete our online form: www.nbt.nhs.uk/patients-carers/feedback/advice-complaints/raise-a-conce…
Email: complaint@nbt.nhs.uk
Phone: 0117 414 4567
Write to:
Complaints Team,
Beaufort House,
Southmead Hospital
Bristol
BS10 5NB
© North Bristol NHS Trust. This edition published February 2024. Review due February 2027. NBT002933
Department of Neuropsychology
Rosa Burden Centre
Donal Early Way
Southmead Hospital
Bristol
BS10 5NB
Phone: 0117 414 0454
Email: neuropsychology@nbt.nhs.uk
The Department of Cellular Pathology provides a wide-ranging and comprehensive Histopathology, diagnostic Cytopathology and Cervical cytology screening service to both North Bristol NHS Trust and University Hospitals Bristol NHS Trust, as well as GPs and other healthcare providers. The service is accredited to ISO15189:2012 with UKAS (Lab 8130) and relevant activities are licensed by the Human Tissue Authority (license 12413). There is extensive participation in External Quality Assurance schemes. The department is well-equipped and is housed in a purpose-designed laboratory opened in 2016.
The Department is open for service and opinion Monday to Friday, 09.00–17.00 hrs. Outside of these times, a renal on-call service exists and contact with on-call consultant staff can be made via switchboard. There is no general on-call service.
The diagnostic service in fully computerised with extensive databases. The current LIMS is Clinisys WinPath Enterprise. Results are all available through ICE and all requesting can be made through ICE.
The service has implemented specialist reporting to support the wide range of services at the Trusts. The consultants are members of one or more specialist teams working to common standards. Clinical consolidation of services had brought together the work of some teams whilst in others cellular pathology has instigated this. A number of the consultants support referral practices and, in all specialisms, consultants are core members of the multidisciplinary teams for cancer services.
The department works closely with the Bristol Genetics Laboratory for the provision of a portfolio of molecular genetics testing.
Services offered include consultation with clinical colleagues to assist in the interpretation of reports and to provide advice about the collection, handling, fixation and submissions of specimens for investigation.
A number of individuals in the department have research interests and the department as a whole is keen to support such activity within the Trusts.
The accreditation status of our tests can be found in the Quality section of the Severn Pathology website.
Cytology
Laboratory Opening Hours:
Monday - Friday, 9am - 5pm
Tel: 0117 4149889
Fax: 0117 4149389
Histology
Tel: 0117 414 9890
Fax: 0117 414 9390
Includes details of sample types, volumes, special precautions, turnaround times & reference ranges.
You are being offered this test because of your breast cancer diagnosis and because you meet the current national criteria for genetic testing.
The test may give us information about why you developed breast cancer and about your risks of developing new cancers in the future. As this test looks for inherited (germline) variants, it may have implications for your future health and for your family. If we find that you have an increased risk of future cancers’ we will discuss screening and risk reducing methods with you.
Please take time to ask all the questions that you need to. If you don’t feel ready to have a test right now, your team can store a DNA sample and revisit this with you at a later date. If you decide not to have a genomic test you will still get the best possible health care, based on what we know about your cancer.
Most breast cancer is not inherited. Breast cancer is a common condition, it affects around one in seven women in the UK. Only a minority of breast, around 5-10%, are influenced by a genetic variant. Genes which influence breast cancer risk generally fall into one of two categories:
High risk breast cancer genes. These genes can cause a high lifetime risk of breast cancer. High risk is defined as a lifetime breast cancer risk of 30-80%. Examples of high risk genes include BRCA1, BRCA2 and PALB2. These genes also influence the risk of ovarian cancer. There may be some increased risk of other cancers, depending on family history.
Moderate risk breast cancer genes. These genes increase breast cancer risk, but not as strongly as the high risk genes. Moderate risk genes typically cause a lifetime breast cancer risk of 20-30%, depending on family history. Examples of moderate risk genes include CHEK2 and RAD51C. Some of these genes also influence ovarian cancer risk. Moderate risk genes were discovered more recently, so we are still learning about their effect on cancer risk.
Inheritance: If a parent has a gene variant, there is a 50% chance of passing it on each time they have a child. This is not influenced by sex; we all have these genes and either parent can pass them on to any child.
Genomic testing in inherited Breast Cancer (Test Code R208) is carried out on a blood sample.
If you decide to have the R208 genetic test, your healthcare professional will discuss this with you and there is a form to complete which records your choices. Your blood sample will be sent to our regional Genomics Laboratory Hub for testing. Testing usually takes between 2 to 3 months. This test is about your cancer and inherited breast cancer risk, it does not look for changes in DNA that may cause other health conditions.
The R208 gene panel includes a number of genes and the laboratory will add to it as we learn more about cancer genetics. Only genes with a proven influence on breast cancer risk will be added. If you have specific questions about the genes currently included in the R208 test, please discuss these with your healthcare professional. If required, you have the option to speak to a genetic specialist before making your decision about testing. Everyone who tests positive, or has a significant family history, will be offered a referral to a genetic specialist.
Once your sample has been taken the results are returned to your healthcare professional who will share them with you. There are three outcomes to this genetic test:
Positive: A variant is found in a breast cancer gene.
Negative (normal): No variants were found in the genes tested.
Inconclusive: A gene variant was found but its significance is unclear.
1. What does it mean if a gene variant is found on my genetic test?
This is likely to explain why you developed breast cancer. Your breast cancer team will inform you of the result and consider this information when planning your treatment.
You will be referred to Clinical Genetics so that you can discuss your result in more detail. Clinical Genetics will explain what the test result means for your future risk of cancer, your options for cancer screening and measures to reduce these risks.
A test will be available for your relatives to assess their genetic cancer risk. Clinical Genetics will support you in sharing the information with family members, so that everyone gets the care they need.
2. What does it mean if no gene variants are found on my genetic test?
This is the most common result. This result means it is unlikely that your breast cancer was caused by an inherited gene variant. The risk of future cancers (in you or your relatives) is unlikely to be raised unless you have a significant family history of cancer.
If you have a significant family history of cancer you will be referred to Clinical Genetics for further discussion.
3. What does an inconclusive result mean?
People are diverse and there is a lot of variation within our genes. Some gene variants have no effect on how a gene functions. If a new or rare variant is picked up, it can hard to predict whether it affects cancer risk, or whether it is just harmless variation.
If the scientists cannot be sure of a variant’s effect, they will report it as an uncertain finding. (In technical terms this is called a “variant of uncertain significance”, or “VUS”). If an uncertain variant is found, you may be referred to Clinical Genetics so that they can assess this for you and your family.
Cancer occurs when damage inside of a cell results in that cell growing and dividing in an uncontrolled manner. Some cancers are triggered by specific environmental factors, such as smoking, UV light or radiation. Most cancers involve a number of different factors and are essentially a chance event, one that becomes more common as we age. In a small number of cases cancer can be caused by an inherited gene “variant”, one that can be passed on between generations.
Genomic testing is increasingly being used in cancer treatment pathways. This kind of testing may help us to understand:
• Why you developed a cancer
• Which treatments may be most effective for your cancer
• If you are at risk of developing a further cancer in the future and potential screening and risk reducing options
• Whether your relatives are at increased risk of cancer
A gene is a specific sequence of DNA. Each gene performs a particular role in the body, some genes help to prevent cancer. A “variant” is a different code to the standard gene sequence. Changes to the gene sequence can affect how the gene functions.
The exact effect depends on the gene involved. There are different types of genetic tests: inherited (germline) and cancer-specific (somatic).
This test, called R208, is an inherited variant test. This test can pick up gene variants that are present in all of your cells and have been present since you were born. Your DNA is a combination of both of your parents, so this type of gene variant is usually inherited. Inherited (germline) variants may tell us why a cancer occurred. These variants may also predict the risk of future cancers, in you and your relatives.
This is separate to the R208 test but might be mentioned by your cancer treatment team. A somatic test looks at the DNA in your tumour, rather than the DNA in the rest of your body. These variants are not inherited and cannot be passed on. Somatic variants may give us information about your cancer type, or what treatment is most suitable for you.
The R208 genes primarily influence breast and ovarian cancer risk. Some R208 genes also influence the risk of other cancers, although this risk is smaller than the risk of breast cancer. Associated cancers can include; ovarian cancer for women. Pancreatic and skin cancer for men and women. As well as prostate and male breast cancer for men.
Your genomic data and samples will be stored as part of your health record. DNA samples may be used anonymously for quality control. All data is kept securely and confidentially in line with UK law and NHS policy. More information can be found at www.england.nhs.uk/contact-us/privacy-notice Information in this guide should be used to supplement professional advice specific to your circumstances. If you have any questions, it is important to ask your medical team
‘BReast CAncer Genes and Me’ is a digital patient empowerment project that’s set to transform the experience of people with a diagnosis of breast cancer that might have implications on other family members.
The project introduces the concept of genetic testing for breast cancer in an accessible format, presented as a six-part series of colourful animations. Each video features digestible information accompanied by gentle music and a clear voiceover that takes the participant through the process and implications of genetic testing.
This project has been developed as part of a Collaborative Working initiative between the South West Genomic Medicine Service Alliance and AstraZeneca UK, and has been co-designed by clinicians and patients alike, providing an overview of the genetic testing pathway from start to finish. We have been working with Magentus Global Health Tech for our digital solution.
BReast CAncer Genes and Me aims to streamline the consent process for breast cancer genetic testing through a digital consent pathway, supporting patients and their families through every stage and guiding them to become confident decision-makers.
The Acute Oncology Clinical Nurse Specialists are experts in acute cancer care; we work as part of the Cancer Support Team. We can answer your questions and give you information about your diagnosis, treatment, and support available during and after your care.
The Cancer Support Team also has support workers. They are trained to provide support and information about physical, emotional, and practical concerns to help you self-manage your recovery, and return to a healthy lifestyle as soon as possible.
Personalised Care and Support Planning is a conversation and assessment you will be offered with your Clinical Nurse Specialist and/or Cancer Support Worker, to help you discuss your health and wellbeing in relation to your cancer. It will assess your individual needs and concerns, to understand what matters to you.
Personalised Care and Support Planning includes sharing information with you about diet, physical activity, fatigue, and other practical information relevant to you. This may include anything from emotional support, to signposting you to local support services such as benefits advice.
At NBT we encourage you to be a partner in your healthcare.
When patients work with healthcare professionals to make decisions about their healthcare, this is called shared decision making. Shared decision making ensures that you are supported to make decisions that are right for you. It means supporting you to choose tests and treatments based on medical evidence, as well as your individual preferences, beliefs, and values.
It can be helpful to write down questions you have for your healthcare team. You should bring these, and a pen and paper to make any notes when you have appointments.
Some questions that may be helpful to ask:
Shared decision making matters to us. Tell us what matters to you.
We offer help and information about different kinds of cancers and treatments. We also talk about money, benefits you might get, what to eat, and exercises to do. If you have concerns or just want to talk with one of the team, we have time to listen and help you.
The centre offers ‘drop-ins’ for coffee and a chat or appointments for specific needs.
Opening times: Monday to Friday 08:30 - 16:15
Phone number: 0117 414 7051
As part of your routine care you may be invited to a group education and support session at or soon after the time of a cancer diagnosis.
The session provides:
Venue: NGS Macmillan Wellbeing Centre, Southmead Hospital
Days and times: Monday 13:30 - 14:30, Thursday 10:00 - 11:00.
Acute Oncology Clinical Nurse Specialists
Gate 10, Brunel building
Southmead Hospital
Bristol
BS10 5NB
Acute Oncology Number 07860 783116
Macmillan Wellbeing Centre 0117 414 7051
© North Bristol NHS Trust. This edition published June 2024. Review due June 2027. NBT002801.
If you have a goal to review your medication, this will need to be with your GP or pharmacist. We do not prescribe medications in pain management, however we can help advise you how to make a plan towards achieving your medication goals.
We know pain impacts on many areas of life and often people must adapt to changes in their circumstances. Living with pain has many challenges and pain psychology supports people to re-build their lives and adapt to change, develop coping strategies, and support their emotional wellbeing.
Pain management focusses on the strategies you can put in place to minimise the impact pain has on daily life. We do not offer medical investigations and for most people medical investigations have been completed. If you are concerned in relation to medical problems, it would be advisable to discuss this with your GP.
Chronic / persistent pain is a very common problem. Pain is complicated and often there are many automatic systems involved in long term pain. It is recognised as a long-term condition and is very real.
Physiotherapists in pain management look at all the factors impacting on function and pain levels. It is important to develop functional abilities and activity, whilst improving the control of pain. The physiotherapist will work with you to find a successful level of activity that can then improve over time. This may be a different approach to previous experiences.
We will tailor the support that you receive in the pain management service to you, so everyone’s route through will be slightly different. It might be that when you come to the end of the work that you do with us you might be signposted elsewhere. Or it might be that you take some time to put the strategies that you have learned into practice for yourself.
© North Bristol NHS Trust. This edition published January 2025. Review due January 2028. NBT003762
For all appointment enquiries, please contact:
Pain Management
Gloucester House
Southmead Hospital
Telephone: 0117 414 7357
email: painmanagementcentre@nbt.nhs.uk
Please note that we are not a crisis service and we may not be able to answer your call but you are more than welcome to leave us a voice message and we will get back to you within 2-3 working days.
If you need urgent medical support or advice you will need to contact your GP, or phone 111 or 999.
If you feel you need emotional support urgently, please contact your GP, or phone 111.
If you wish to speak to to the Pain Clinic, please visit the Pain Clinic page.
The Department of Infection Sciences is a collaboration between the North Bristol NHS trust and UK Health Security Agency to provide a hospital-based service for the laboratory diagnosis and clinical management of microbial diseases for patients both in hospital and the community, together with advice on the control of infection.
Laboratories participate and perform well in national quality assurance schemes and is fully accreditied. They are accredited for training with the Institute of Biomedical Science and registration with the Health Care Professions Council and the Royal College of Pathologists.
Medical microbiologists are available, both during the day and out-of-hours, to give advice concerning the diagnosis, treatment, and monitoring of infectious diseases. Where appropriate, preliminary reports and results are phoned to the clinician concerned. Ward rounds are conducted daily to review and offer advice on the management of inpatients with serious infections.
An active Infection Control Team is available at all times to help with matters relating to the control and prevention of infection.
General Enquiries/Results/Clinical Advice
Southmead Hospital telephone: 0117 4146222
Email: microbiology@nbt.nhs.uk
Laboratory Hours
Monday to Friday 9am - 5.15pm
Saturday 9am 12 noon
A 24-hour on-call service operates outside normal laboratory hours - please contact via switchboard.
Get the Badger Notes app or visit the website:
If you have used Badger Notes at a different trust or in a previous pregnancy, please see "Adding your pregnancy to an existing account" section below.
You will need:
To create your account:
You can change you Badger Notes language through the tab with your current chosen language:
You will need:
To add your pregnancy:
You will have the opportunity to complete your pre-booking questionnaire before your booking appointment with your community midwife. You can return to the questionnaire and update up to the day of your booking appointment.
You can change your phone number or email address associated with your Badger Notes log in through the Edit Profile tab.
(This does not update the phone number or email address that the hospital has on record for you, to do this you will need to speak to your community midwife).
Your care provider may ask you for key details such as your hospital number, if you contact them over the phone.
The key details are:
To find these details:
We recommend you have push notifications switched on to allow appointment reminders and important updates from our maternity unit.
To change notification settings:
In the Care Plan tab, you can see a weekly summary of your pregnancy.
For example at 28 weeks, you will be offered routine screening blood tests and recommended to read the information leaflet on screening.
You will be able to:
In the conversations tab, you can:
Your midwife or doctor will be able to see these notes however they will not be notified of an entry therefore it is very important not to put any urgent messages in this area.
A summary of your maternity notes can be found within the Maternity Record tab.
To view your antenatal care summary:
You may need to turn your phone landscape to make viewing easier.
Our hospital maternity leaflets are available in the Badger Notes Library tab.
These can be viewed throughout your pregnancy and after birth.
You can also access the Glossary to help you understand any new medical terms you may see in your notes.
Leaflets which have been specifically recommended to you by your midwife or doctor can be found by:
To view your hospital contacts, including emergency phone numbers:
If you have any problems accessing your Badger Notes, please use the Badger Notes Helpline where someone will be able to help you.
Please note this is a non-urgent helpline for Badger Notes access queries only.
Phone 0117 342 9301
Email badgernotessupport@uhbw.nhs.uk
Open hours:
© North Bristol NHS Trust. This edition published December 2024. Review due December 2027. NBT002914.